Is race a risk factor for allogeneic marrow transplantation?

Area of Science:

• Hematology
• Immunology
• Transplantation Medicine

Background:

• Race can influence health outcomes, but its impact on HLA-identical marrow transplantation is not fully understood.
• Previous research has not comprehensively evaluated racial disparities in hematopoietic stem cell transplantation (HSCT).

Purpose of the Study:

• To investigate the influence of race as a risk factor for outcomes in HLA-identical marrow transplantation.
• To compare survival rates and complications among different racial groups undergoing HSCT for specific hematologic malignancies and aplastic anemia.

Main Methods:

• Retrospective analysis of actuarial survival at 2 years post-grafting.
• Comparison of survival, engraftment, and graft-versus-host disease (GVHD) incidence.
• Data collected from patients transplanted between 1971 and 1985 for aplastic anemia, acute non-lymphocytic leukemia (ANLL), and acute lymphoblastic leukemia (ALL).

Main Results:

• No significant differences in engraftment or survival were observed among racial groups for aplastic anemia.
• Black patients with ANLL exhibited significantly lower survival rates (P = 0.03) compared to other racial groups.
• Survival rates for acute lymphoblastic leukemia were comparable across all racial groups.
• Graft-versus-host disease incidence was similar across groups, with a slight increase noted in Black patients with ANLL.

Conclusions:

• Race does not appear to be a significant risk factor for outcomes in HLA-identical marrow transplantation for aplastic anemia and ALL.
• Lower survival in Black patients with ANLL warrants further investigation to identify underlying causes.
• Larger patient cohorts are needed to draw definitive conclusions regarding racial disparities in HSCT outcomes.